Navigation Links
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
Date:2/4/2009

FRAZER, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that Sarma P. Duddu, Ph.D., has been appointed as General Manager and Vice President of Drug Delivery Technologies of CIMA LABS, Inc. In this role, Dr. Duddu will lead all aspects of the Cephalon drug delivery business at CIMA, its wholly owned drug delivery subsidiary located in suburban Minnesota.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090204/PH66729 )

In his new role, Dr. Duddu will be a member of the Cephalon Technical Operations leadership team and will report directly to Peter E. Grebow, Ph.D., Executive Vice President of Worldwide Technical Operations.

"We are pleased with the strong record of successful drug development that Sarma brings to our organization," said Peter Grebow, Ph.D., Executive Vice President Worldwide Technical Operations. "His extensive experience in drug delivery and previous leadership roles in R&D, product development and new product research make him well qualified to not only lead, but to strengthen and grow our drug delivery business."

Dr. Duddu has more than 15 years of pharmaceutical experience and has been involved in all aspects of the drug delivery business. Most recently, he held the position of vice president of pharmaceutical development at Nektar Therapeutics (formerly Inhale Therapeutic Systems) based in San Carlos, CA. Previously at Nektar, Dr. Duddu held key management positions in product development, R&D operations, corporate development and strategy, as well as new product research. Prior to Nektar, he worked at SmithKline Beecham Pharmaceuticals in King of Prussia, PA, where he focused in the areas of phar
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , ATLANTA, Dec. 1 /PRNewswire-FirstCa...VX) (the "Company"), an Atlanta-based, biopharmace...ses caused by HIV-1 (Human Immunodeficiency Virus)...support for World AIDS Day. ,, "Today is the 21...that have lost their fight with the HIV/AIDS pande...
(Date:12/1/2009)..., A new clinical study pr...edicine shows that three-dimensional (3-D) automat...AVC software during an in vitro fertilization (IVF...tional manual measurement of the follicles. , ..., 2009 -- The Advanced Fertility Center of Chicago...
(Date:12/1/2009)..., iCardiac now provides s...tical companies. , Roches...ologies, Inc., a global leader in advanced cardiac...y that a top five pharmaceutical company has selec... services. iCardiac will provide Highly Automated...
(Date:12/1/2009)..., Michael R. Drapp, a 34-...formed nanoEdge™ Technologies, a business de...pany focused on the emerging nanotechnology space....chnologies and act as a nanotechnology incubator. ...cember 1, 2009 -- Michael R. Drapp , a 34-year ve...
Breaking Biology Technology:GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
...municipalities are fighting AT&T about Project Lig...ns, others are looking at major fiber-optic invest... in Utah as we mentioned in last week,s column, th...e Midwest. As one CIO in Jacksonville, Fla. wrote...mes worldwide have a broadband connection to the o...
...s. - In the first partnership of its new joint-ve...nd Innovation will market and license 10 United S...national Specialty Products . , ,The joint venture...uiring underutilized, or "off-strategy" technologi...existing companies in southeastern Wisconsin. , ,I...
.... - Ravi Kalla is more than the CEO of a custom s... Madison and India, he is pretty well plugged in t... a member of Gov. Jim Doyle,s eHealth Care Qualit...mplementation of electronic health records. , ,Fo...ust a couple of years away, he has some deflating ...
Other Biology Technology:Fiber-optic infrastructure spurring city economic development 2Fiber-optic infrastructure spurring city economic development 3Fiber-optic infrastructure spurring city economic development 4CATI venture part of new tech-transfer strategy 2CATI venture part of new tech-transfer strategy 3Kalla: Have patience with electronic health records 2Kalla: Have patience with electronic health records 3Kalla: Have patience with electronic health records 4Kalla: Have patience with electronic health records 5
(Date:11/30/2009)...A new scientific organisation is needed to monitor...ountries at Copenhagen to cut their deforestation ...Leeds. , Existing government agencies and resear...sands of satellite images of the Earth,s surface c..., Now, a paper published by Dr Alan Grainger in ...
(Date:11/30/2009)..., CLEMSON Clemson University researchers Ron Falt...ronmental Protection Agency grant to study the saf...ns located deep below the earth,s surface. , Wit...ls believed to be the leading cause of global warm...t promising alternatives for reducing emissions us...
(Date:11/30/2009)... This release is available in German . , Th...laborative Research Centres as of 1 January 2010. ...ants Committee in Bonn. The new centres will initi...million. In addition, 20 percent overhead funding ...project. The centres, research topics range from m...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 1Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 2Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 1Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 2Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 3Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 4New Fertility Treatment Option Now Available for Cancer Patients 54313 1New Fertility Treatment Option Now Available for Cancer Patients 54313 2New Fertility Treatment Option Now Available for Cancer Patients 54313 3New Fertility Treatment Option Now Available for Cancer Patients 54313 4
...al flower, which could offer hope for sufferers of... scale manufacture by Cardiff University,s Manufac...ease is the most common form of dementia, making u...ffects one person in 20 over the age of 65 and one...cies of daffodil, which thrive in the Black Mounta...
... they are a step closer to a technique to easily d...come apparent. , The findings, currently online in...es, involve introducing molecularly engineered str...er they unleash a fluorescent burst after they adh...able doctors to search within extremely complex fl...
...ve created a larger-than-normal DNA molecule that ...e findings, reported in the Oct. 25 online edition...ences (PNAS), may reveal new insights into how gen... replication-arise. The discovery was made in the ...at Stanford and co-author of the PNAS study. , DNA...
Other Biology News:Scientists closer to new cancer detection method 2Scientists closer to new cancer detection method 3DNA size a crucial factor in genetic mutations, study finds 2DNA size a crucial factor in genetic mutations, study finds 3
Fluorescent Standards Blue Standard from Invitrogen
Fluorescent Standards Cyan Standard from Invitrogen
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE) from Molecular Probes (Invitrogen)
Rabbit Anti-Human ECE1 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: